ClinicaliQ Trial Snapshot
- Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib — Recruiting • Phase III • Respiratory / COPD / Asthma • NCT06855498.
- Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.
- Sponsor: Incyte Corporation.
Verify eligibility, endpoints and current status on the original source registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.
Eligibility Snapshot
- : * Ability to comprehend and willingness to sign a written ICF for the study. * Completed the treatment period of a predetermined, Incyte-sponsored, povorcitinib parent study without safety or tolerability concerns, per investigator's assessment. * Received clinical benefit from treatment with study drug during the parent study, as determined by the investigator. * Demonstrated compliance, as assessed by the investigator, with the parent Protocol requirements. * Willingness to avoid pregnancy or fathering children as defined in the protocol. * Willingness and ability to comply with the study Protocol and procedures.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.